Navigation Links
Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
Date:10/14/2008

MOUNTAIN VIEW, Calif., Oct. 14 /PRNewswire/ -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., applauds the three winners of the 2008 Nobel Prize in Chemistry; Drs. Osamu Shimomura, Martin Chalfie, and Roger Y. Tsien, for the discovery and development of the green fluorescent protein (GFP) and a wide array of related fluorescent proteins. The application of fluorescent proteins as a research tool has revolutionized life science research and biotechnology: they enable researchers to monitor cellular activity in real time, characterize gene expression, and localize specific proteins, organelles, or cells of interest. Thus, fluorescent proteins have facilitated many groundbreaking discoveries in cell biology over the past decade.

"As a long-standing leader in the fluorescent protein field, Clontech is proud to have been the first company to commercialize the GFP technology that was developed by Dr. Chalfie and Dr. Douglas Prasher, enabling GFP to be used as a tool for cell biology research. Currently, we offer many fluorescent proteins that build upon the work of these three exceptional scientists, including the Fruit Fluorescent Proteins developed by Dr. Tsien," said Carol Lou, General Manager of Clontech Laboratories, Inc.

GFP was initially discovered and characterized by Dr. Shimomura, who isolated it from the jellyfish Aequorea victoria and discovered that it glowed bright green under ultraviolet light. Dr. Chalfie applied GFP to biological research, using it as a visual genetic tag to study biological phenomena in the bacterium Escherichia coli and the model organism Caenorhabditis elegans. Dr. Roger Y. Tsien, a Howard Hughes Medical Institute Investigator of the University of California, San Diego, furthered our general understanding of how GFP fluoresces and has engineered many fluorescent proteins, spanning a wide spectrum of colors not found in nature. The use of these different colored variants has enabled scientists to follow several different biological processes at the same time.

About Clontech Laboratories, Inc.

Clontech Laboratories, Inc. develops, produces, and markets leading-edge biological products to the life science market worldwide. Clontech has approximately 2,000 products that enable life science researchers to study genes, their products, and their cellular function through the use of innovative and powerful tools for gene cloning, labeling, and expression; as well as for elucidating protein:protein interactions; isolating and purifying DNA and proteins; and conducting a wide variety of PCR experiments. Clontech is a wholly-owned subsidiary of Takara Bio Inc. For more information visit http://www.clontech.com

About Takara Bio Inc.

Takara Bio Inc. is an innovative biotechnology company based in Shiga, Japan. As a world leader in biotechnology research and development, Takara Bio was the first company to market PCR technology in Japan and is also the developer of the RetroNectin(R) reagent, which is a world-standard in gene therapy protocols. In addition to providing research reagents and equipment to the life science research market, Takara Bio has active research and product development activities in the fields of gene and cell-based therapy, and agricultural biotechnology; and is committed to preventing disease and improving the quality of life for all people through the use of biotechnology. Through strategic alliances with other industry leaders, the Company aims to extend its reach around the world. More information is available at http://www.takara-bio.com


'/>"/>
SOURCE Clontech Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems
2. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings
3. Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger
4. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009
5. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation from Board of Directors of Jitendra Doshi and Appointment of GP Singh Sachdeva
6. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 First Quarter Earnings
7. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
8. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
9. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
10. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
11. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... to accelerating the fight against cancer, autoimmune disease and more through a single-cell ... single-cell metabolomics and proteomics analysis platform developed in the laboratory of Dr. ...
(Date:3/27/2017)... March 27, 2017 Infectex Ltd., a Russian portfolio company of ... study of SQ109 added to the standard drug therapy regimen in patients with multidrug-resistant ... Sequella, Inc. ( USA ) and the US National Institutes of Health. ... ... Biotech Venture Fund Logo ...
(Date:3/27/2017)... , March 27, 2017 The ... to a comprehensive library of reports on Valero Energy ... transportation fuels and petrochemical industries. ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO) ... biofuel production to go green. Ethanol today, even though touted ...
(Date:3/27/2017)... -- Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, ... Welch , will be presenting at this year,s MicroCap ... at the Essex House in New York ... Mark Erlander , Ph.D., will also be available ... The presentation will be webcast live at http://wsw.com/webcast/microcapconf3/trov ...
Breaking Biology Technology:
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/20/2017)... , March 20, 2017 PMD Healthcare ... personal spirometer and Wellness Management System (WMS), a remote, ... Founded in 2010, PMD Healthcare is a Medical Device, ... a mission dedicated to creating innovative solutions that empower ... With that intent focus, PMD developed the first ever ...
(Date:3/7/2017)... Brandwatch , the leading social intelligence company, today ... to uncover insights to support its reporting, help direct future ... UK,s leading youth charity will be using Brandwatch Analytics social listening ... better understanding of the topics and issues that are a priority ... ...
Breaking Biology News(10 mins):